LGALS1 and type 2 diabetes mellitus: We have also observed a strong cross-sectional association between circulating levels of galectin-1 and several markers of the metabolic syndrome in a population-based cohort, but BMI-adjusted galectin-1 levels were lower in individuals with type 2 diabetes [17].